Alkem Laboratories Ltd (ALKEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1000019, "name": "Alkem Lab", "stock_name": "Alkem Lab", "full_name": "Alkem Laboratories Ltd", "name_url": "stocks-analysis/alkem-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "5,350.15", "chg": 35.8, "chgp": "0.67%", "dir": 1, "prev_price": "5,314.35", "mcapval": "64,314.00 Cr", "mcap": "Mid Cap", "scripcode": 539523, "symbol": "ALKEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE540L01014", "curr_date": "Aug 28, 03:30 PM", "curr_time": "21:42 PM", "last_traded_at": "Aug 28, 03:30 PM IST", "bse_nse_vol": "2.32 lacs", "exc_status": "Active", "traded_date": "Aug 28, 2026", "traded_date_str": "2026 08 28", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Golden Cross Confirmed: Do Alkem Laboratories Ltd's Other Technical Indicators Agree?", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4173786", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_goldencross_4173786.png", "date": "2026-08-28 18:00:34", "description": "The 50-day moving average has crossed above the 200-day moving average for Alkem Laboratories Ltd on 28 Aug 2026, signalling a golden cross. Yet, the broader technical landscape presents a nuanced picture, with some indicators supporting the crossover while others remain cautious. This divergence invites a closer examination of the signal's reliability in the current market context." }, { "title": "Alkem Laboratories Sees Significant Open Interest Surge Amidst Weak Price Action", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-significant-open-interest-surge-amidst-weak-price-action-4167180", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_oi_spurts_by_underlying_4167180.png", "date": "2026-08-24 15:00:38", "description": "Alkem Laboratories Ltd has witnessed a notable 12.6% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s underperformance relative to its sector and broader indices. This surge in open interest, coupled with subdued price movement and declining investor participation, suggests evolving market positioning and potential directional bets among traders." }, { "title": "Alkem Laboratories Ltd Ends Week Flat Despite Mixed Signals and Rising Derivatives Activity", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-ends-week-flat-despite-mixed-signals-and-rising-derivatives-activity-4165197", "imagepath": "", "date": "2026-08-22 13:04:31", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>17 Aug:</strong> Q1 2026 results show stabilisation amid margin pressures</p>\n <p><strong>18 Aug:</strong> Mojo Grade upgraded from Sell to Hold reflecting improved metrics</p>\n <p><strong>18 Aug:</strong> Valuation shifts signal renewed price attractiveness</p>\n <p><strong>21 Aug:</strong> Sharp open interest surge amid mixed price action</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.5,399.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div clas..." }, { "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Price Action", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-mixed-price-action-4164439", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_oi_spurts_by_underlying_4164439.png", "date": "2026-08-21 15:01:05", "description": "Alkem Laboratories Ltd has witnessed a notable 11.03% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock traded in a narrow range and remains below key moving averages, reflecting a cautious stance among traders amid sectoral and broader market fluctuations." }, { "title": "Alkem Laboratories Upgraded to Hold as Financial and Valuation Metrics Improve", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-upgraded-to-hold-as-financial-and-valuation-metrics-improve-4159145", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_mojoScore_4159145.png", "date": "2026-08-18 08:50:13", "description": "Alkem Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across financial performance, valuation, and technical indicators. Despite some challenges in quarterly profits and rising interest costs, the company’s robust return on capital and attractive valuation metrics have contributed to a more balanced outlook for investors." }, { "title": "Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-valuation-shifts-signal-renewed-price-attractiveness-4158604", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_valuationdot_4158604.png", "date": "2026-08-18 08:01:45", "description": "Alkem Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to an attractive price territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, marks a significant development for investors assessing the pharmaceutical giant’s market appeal amid a challenging sector backdrop." }, { "title": "Alkem Laboratories Ltd Q1 2026: Financial Trend Stabilises Amid Margin Pressures", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-q1-2026-financial-trend-stabilises-amid-margin-pressures-4156845", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_fintrenddot_4156845.png", "date": "2026-08-17 08:00:24", "description": "Alkem Laboratories Ltd’s latest quarterly results for June 2026 reveal a stabilisation in financial performance after a period of decline, with the company’s financial trend improving from negative to flat. Despite a robust return on capital employed (ROCE) of 20.21%, the pharmaceutical firm faces challenges from a significant contraction in profit after tax (PAT) and rising interest expenses, signalling margin pressures amid a competitive sector environment." }, { "title": "Alkem Laboratories Ltd Falls 4.11%: 3 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-falls-411-3-key-factors-driving-the-weekly-decline-4155484", "imagepath": "", "date": "2026-08-15 13:03:45", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>10 Aug:</strong> Stock opens at ₹5,536.05, down 1.68% amid mixed market sentiment</p>\n <p><strong>12 Aug:</strong> Technical momentum shifts to mildly bearish; Mojo Grade downgraded to Sell</p>\n <p><strong>12 Aug:</strong> Valuation metrics signal expensive price levels relative to peers</p>\n <p><strong>14 Aug:</strong> Open interest surges 51.5% despite continued price weakness</p>\n <p><strong>14 Aug:</strong> Week closes at ₹5,399.00, down 0.36% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div>..." }, { "title": "Alkem Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-sell-4155111", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_mojoScore_4155111.png", "date": "2026-08-15 10:10:26", "description": "Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing." } ], "total": 652, "sid": "1000019", "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019" }, "announcements": [ { "caption": "Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011", "datetime": "26-Aug-2026", "details": "The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for HDFC Mutual Fund", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "20-Aug-2026", "details": "Please find attached herewith Q1 FY27- Earnings Call Transcript.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "20-Aug-2026", "details": "Please find attached herewith Q1 FY27- Earnings Call Transcript.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Alkem Laboratories Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Aug 26", "dt": "2026-08-07", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

17 Aug: Q1 2026 results show stabilisation amid margin pressures

18 Aug: Mojo Grade upgraded from Sell to Hold reflecting improved metrics

18 Aug: Valuation shifts signal renewed price attractiveness

21 Aug: Sharp open interest surge amid mixed price action

Week Open

Rs.5,399.00

Week Close

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Mixed Price Action

2026-08-21 15:01:05

Alkem Laboratories Ltd has witnessed a notable 11.03% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this surge, the stock traded in a narrow range and remains below key moving averages, reflecting a cautious stance among traders amid sectoral and broader market fluctuations.

Read full news article

Alkem Laboratories Upgraded to Hold as Financial and Valuation Metrics Improve

2026-08-18 08:50:13

Alkem Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced improvement across financial performance, valuation, and technical indicators. Despite some challenges in quarterly profits and rising interest costs, the company’s robust return on capital and attractive valuation metrics have contributed to a more balanced outlook for investors.

Read full news article

Alkem Laboratories Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-08-18 08:01:45

Alkem Laboratories Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to an attractive price territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, marks a significant development for investors assessing the pharmaceutical giant’s market appeal amid a challenging sector backdrop.

Read full news article

Alkem Laboratories Ltd Q1 2026: Financial Trend Stabilises Amid Margin Pressures

2026-08-17 08:00:24

Alkem Laboratories Ltd’s latest quarterly results for June 2026 reveal a stabilisation in financial performance after a period of decline, with the company’s financial trend improving from negative to flat. Despite a robust return on capital employed (ROCE) of 20.21%, the pharmaceutical firm faces challenges from a significant contraction in profit after tax (PAT) and rising interest expenses, signalling margin pressures amid a competitive sector environment.

Read full news article

Alkem Laboratories Ltd Falls 4.11%: 3 Key Factors Driving the Weekly Decline

2026-08-15 13:03:45

Key Events This Week

10 Aug: Stock opens at ₹5,536.05, down 1.68% amid mixed market sentiment

12 Aug: Technical momentum shifts to mildly bearish; Mojo Grade downgraded to Sell

12 Aug: Valuation metrics signal expensive price levels relative to peers

14 Aug: Open interest surges 51.5% despite continued price weakness

14 Aug: Week closes at ₹5,399.00, down 0.36% on the day

Week Open

...

Read full news article

Alkem Laboratories Ltd is Rated Sell

2026-08-15 10:10:26

Alkem Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News